In this issue:
Aclidinium reduces exacerbations without increasing risk of MACE
Underlying systemic inflammation in smokers
Increasing prevalence of AF in patients with end-stage COPD
CRP-guided antibiotic treatment in AECOPD
Updated GOLD treatment recommendations
Risk factors for lung cancer in COPD patients
Health literacy and cognitive abilities affect self-management behaviours
Cachexia and associated mortality in COPD
Clinical and economic impact of COPD diagnosis timing
Blood eosinophils, ICS withdrawal and risk of COPD exacerbations
Please login below to download this issue (PDF)